// App-Quantinova.ai

5011 : Whole exome sequencing (WES) of circulating tumor DNA (ctDNA) in patients with neuroendocrine prostate cancer (NEPC) informs tumor heterogeneity.

Researchers

Presenter

  • Himisha Beltran

Principal Investigators

  • Alessandro Romanel

  • Nicola Casiraghi

  • Michael Sigouros

  • Matteo Benelli

  • Jenny Xiang

  • Francesca Demichelis

Medical Centers

  • Weill Cornell Medical College, New York, NY

  • University of Trento, Trento, Italy

  • Centre for Integrative Biology, University of Trento, Trento, Italy

Locations

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved